GSK-2110183C
Title | Journal |
---|---|
The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma. | Blood 20141002 |
Discovery of novel AKT inhibitors with enhanced anti-tumor effects in combination with the MEK inhibitor. | PloS one 20140101 |